Cleveland BioLabs Inc. (CBLI) Dropped -10.97% or -0.17 To Price $1.38 On Thursday


Cleveland BioLabs Inc. (CBLI) dropped -10.97% or -0.17 to $1.38. It is near 21552 shares traded, which is 352.44% compare to the average total volume 6115. The market cap of CBLI is $15.59 million. The year to date change is 14.03%. The 52 week price range is from $1.0 to $3.69. Price of CBLI have changed 7.27% during last week. It have changed 19.23% over last month, -8.82% over last 3 months, -22.11% over last 6 months and -52.31% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CBLI is 1.51. It is 9.42% above current price. The 200-day Moving Averages for CBLI is 2.04. It is 47.83% above current price. The 52-week High is 3.69. It is 167.39% from the current price. The 52-week Low is 1.0. It is -27.54% from current price.

There are some statistics of CBLI. It is has market cap $15.59 million. The share outstanding is 11.30 million. The average volume is 6115. The percent of top 15 Institution holding is 5.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CBLI is -373.05%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CBLI is -52.85%.


Tags:

Share this post